Category: Drug safety and pharmacovigilance

This blog provides specific information on: Table of Contents: Introduction In this write-up, you will have clarity from: Many people believe in a wrong way that solicited and unsolicited refer to the sources of reports, but that is not the case. Here, you will find detailed explanations to help you understand these concepts. Definitions Solicited…

In this detailed blog, we explore into CAPA cases, their workflow, and their significance within pharmacovigilance. Explore further to gain a deeper understanding of how to effectively manage CAPA within this context.

Welcome to our comprehensive blog where we delve into the transformative impact of thalidomide and its lasting influence on the cost burden of drugs in our society today. Gain a deep understanding of how the incident reshaped the way we approach drug development, testing, and regulation.

In this blog, we address the common confusion between adverse reactions and adverse events. We aim to clarify the distinction between these terms that often perplex many individuals. If you are still uncertain about the difference, this blog provides the perfect opportunity to gain clarity and enhance your understanding.

Welcome to our informative article, where we unravel the concept of the Investigational Brochure (IB). In this comprehensive piece, we aim to provide a clear understanding of what an IB is, its purpose, significance, and the important components it comprises.

This detailed blog offers insights into lesser-known alternatives to MedDRA, providing valuable information about alternative classifications endorsed by recognized authorities, which might not enjoy the same level of popularity as MedDRA but are nonetheless produced by reputable organizations.

In this comprehensive blog post, we explore into the concept of temporal relationships within pharmacovigilance, particularly focusing on assessing causality. The discussion includes important insights and illustrative examples to enhance understanding.